Free tool
FAERS Monitor: Testim
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021454 or its brand name (Testim, Testosterone). Reports on generic versions are filed under their own applications.
Reports
22,552
Serious
13,806
61% of reports
Hospitalization
6,137
Death reported
1,106
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,566
- off label use1,302
- fatigue1,272
- pain1,223
- myocardial infarction949
- nausea925
- anxiety923
- headache858
- deep vein thrombosis817
- pulmonary embolism800
- cerebrovascular accident783
- asthenia678
- diarrhoea644
- dizziness635
- dyspnoea614
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 170 |
| 2005 | 138 |
| 2006 | 147 |
| 2007 | 176 |
| 2008 | 210 |
| 2009 | 284 |
| 2010 | 351 |
| 2011 | 396 |
| 2012 | 956 |
| 2013 | 429 |
| 2014 | 787 |
| 2015 | 2,259 |
| 2016 | 1,925 |
| 2017 | 1,307 |
| 2018 | 1,442 |
| 2019 | 1,318 |
| 2020 | 1,254 |
| 2021 | 1,237 |
| 2022 | 1,450 |
| 2023 | 1,565 |
| 2024 | 1,651 |
| 2025 | 1,724 |
| 2026 | 1,376 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,607 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| deep vein thrombosisSignal | 817 | 11.9 | 11.1 | 8,039 |
| pulmonary embolismSignal | 800 | 7.9 | 7.4 | 4,803 |
| myocardial infarctionSignal | 949 | 5.1 | 4.8 | 3,129 |
| cerebrovascular accidentSignal | 783 | 4.3 | 4.0 | 2,006 |
| anxietySignal | 923 | 3.0 | 2.8 | 1,267 |
| pain | 1,223 | 1.9 | 1.8 | 498 |
| asthenia | 678 | 1.7 | 1.6 | 190 |
| fatigue | 1,272 | 1.5 | 1.4 | 238 |
| off label use | 1,302 | 1.4 | 1.3 | 146 |
| headache | 858 | 1.3 | 1.2 | 53 |
| dizziness | 635 | 1.2 | 1.1 | 19 |
| drug ineffective | 1,566 | 1.1 | 1.1 | 18 |
| nausea | 925 | 1.1 | 1.0 | 7 |
| dyspnoea | 614 | 1.0 | 0.9 | 0 |
| diarrhoea | 644 | 0.9 | 0.9 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.